InnoCan Pharma Corporation (INNO)
Market Closed
13 Aug, 20:00
CNSX 
CA$
2. 30
+0.05
+2.2222%
CA$
- Market Cap
- P/E Ratio
- Div Yield
9,110 Volume
- Eps
CA$ 2.25
Previous Close Want to track INNO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InnoCan Pharma Corporation (INNO) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.81M
Trailing P/E (ttm) -5.43
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 0.32
Price/Book (mrq) 1.55
Enterprise Value/Revenue 0.11
Enterprise Value/EBITDA -4.12
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.9K
Average volume (90 days) 895
Price summary
52-Week low 2
52-Week high 21
Beta -
50-Day moving average 2.97
200-Day moving average 5.27
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:65
Last split Date 5 Sep 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.06%
Operating margin -0.1%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 5.6
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.48
Total debt (mrq) -
Total Debt/Equity (mrq) 0.27
Current ratio (mrq) 5.24%
Book value per share (mrq) 1.76
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
